Cargando…
Mechanisms of drug interactions between translation-inhibiting antibiotics
Antibiotics that interfere with translation, when combined, interact in diverse and difficult-to-predict ways. Here, we explain these interactions by “translation bottlenecks”: points in the translation cycle where antibiotics block ribosomal progression. To elucidate the underlying mechanisms of dr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421507/ https://www.ncbi.nlm.nih.gov/pubmed/32782250 http://dx.doi.org/10.1038/s41467-020-17734-z |
_version_ | 1783569983364661248 |
---|---|
author | Kavčič, Bor Tkačik, Gašper Bollenbach, Tobias |
author_facet | Kavčič, Bor Tkačik, Gašper Bollenbach, Tobias |
author_sort | Kavčič, Bor |
collection | PubMed |
description | Antibiotics that interfere with translation, when combined, interact in diverse and difficult-to-predict ways. Here, we explain these interactions by “translation bottlenecks”: points in the translation cycle where antibiotics block ribosomal progression. To elucidate the underlying mechanisms of drug interactions between translation inhibitors, we generate translation bottlenecks genetically using inducible control of translation factors that regulate well-defined translation cycle steps. These perturbations accurately mimic antibiotic action and drug interactions, supporting that the interplay of different translation bottlenecks causes these interactions. We further show that growth laws, combined with drug uptake and binding kinetics, enable the direct prediction of a large fraction of observed interactions, yet fail to predict suppression. However, varying two translation bottlenecks simultaneously supports that dense traffic of ribosomes and competition for translation factors account for the previously unexplained suppression. These results highlight the importance of “continuous epistasis” in bacterial physiology. |
format | Online Article Text |
id | pubmed-7421507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-74215072020-08-18 Mechanisms of drug interactions between translation-inhibiting antibiotics Kavčič, Bor Tkačik, Gašper Bollenbach, Tobias Nat Commun Article Antibiotics that interfere with translation, when combined, interact in diverse and difficult-to-predict ways. Here, we explain these interactions by “translation bottlenecks”: points in the translation cycle where antibiotics block ribosomal progression. To elucidate the underlying mechanisms of drug interactions between translation inhibitors, we generate translation bottlenecks genetically using inducible control of translation factors that regulate well-defined translation cycle steps. These perturbations accurately mimic antibiotic action and drug interactions, supporting that the interplay of different translation bottlenecks causes these interactions. We further show that growth laws, combined with drug uptake and binding kinetics, enable the direct prediction of a large fraction of observed interactions, yet fail to predict suppression. However, varying two translation bottlenecks simultaneously supports that dense traffic of ribosomes and competition for translation factors account for the previously unexplained suppression. These results highlight the importance of “continuous epistasis” in bacterial physiology. Nature Publishing Group UK 2020-08-11 /pmc/articles/PMC7421507/ /pubmed/32782250 http://dx.doi.org/10.1038/s41467-020-17734-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Kavčič, Bor Tkačik, Gašper Bollenbach, Tobias Mechanisms of drug interactions between translation-inhibiting antibiotics |
title | Mechanisms of drug interactions between translation-inhibiting antibiotics |
title_full | Mechanisms of drug interactions between translation-inhibiting antibiotics |
title_fullStr | Mechanisms of drug interactions between translation-inhibiting antibiotics |
title_full_unstemmed | Mechanisms of drug interactions between translation-inhibiting antibiotics |
title_short | Mechanisms of drug interactions between translation-inhibiting antibiotics |
title_sort | mechanisms of drug interactions between translation-inhibiting antibiotics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421507/ https://www.ncbi.nlm.nih.gov/pubmed/32782250 http://dx.doi.org/10.1038/s41467-020-17734-z |
work_keys_str_mv | AT kavcicbor mechanismsofdruginteractionsbetweentranslationinhibitingantibiotics AT tkacikgasper mechanismsofdruginteractionsbetweentranslationinhibitingantibiotics AT bollenbachtobias mechanismsofdruginteractionsbetweentranslationinhibitingantibiotics |